Immunocore Holdings (IMCR) Inventory Average (2022 - 2026)
Immunocore Holdings (IMCR) posted Inventory Average of $7.5 million for Q1 2026, up 20.96% sequentially from $6.2 million in Q4 2025, and up 22.41% YoY from $6.1 million in Q1 2025.
Analysis
Immunocore Holdings (IMCR) Inventory Average (2022 - 2026) Analysis & Trends
Immunocore Holdings has reported Inventory Average for 4 years, with the latest figure at $7.5 million in Q1 2026.
- Quarterly Inventory Average rose 22.41% year-over-year to $7.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.5 million (up 22.41% YoY) and the FY2025 annual result came in at $6.1 million, up 22.53% from the prior year.
- Inventory Average advanced to $7.5 million in Q1 2026 per IMCR's latest filing, from $6.2 million in the prior quarter.
- Over five years, Inventory Average peaked at $7.5 million in Q1 2026 and troughed at $1.1 million in Q4 2022.
- A 4-year average of $5.0 million and a median of $5.3 million in 2024 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2025 and 2026: Inventory Average surged 60.7% in 2025, then rose 22.41% in 2026.
- Over 4 years, Inventory Average stood at $1.1 million in 2022, then surged by 371.66% to $5.0 million in 2024, then increased by 24.42% to $6.2 million in 2025, then climbed by 20.96% to $7.5 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $7.5 million, $6.2 million, and $5.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | 213.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 707.10 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Immunocore Holdings | 1.85 Bn | 965.03 Mn | 114.84 Mn | 8.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.02 Mn |
| Mar 31, 2026 | 7.50 Mn |
| Dec 31, 2025 | 6.20 Mn |
| Sep 30, 2025 | 5.56 Mn |
| Jun 30, 2025 | 6.13 Mn |
| Mar 31, 2025 | 6.13 Mn |
| Dec 31, 2024 | 4.98 Mn |
| Sep 30, 2024 | 3.99 Mn |
| Jun 30, 2024 | 3.81 Mn |
| Mar 31, 2024 | 4.33 Mn |
| Dec 31, 2022 | 1.06 Mn |